Analystreport

Akebia Therapeutics (AKBA) had its price target lowered by BTIG Research from $5.00 to $4.00. They now have a "buy" rating on the stock.

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations